School of Medicine
Showing 101-150 of 749 Results
-
Philip C. Hanawalt
Dr. Morris Herzstein Professor in Biology, Emeritus
Current Research and Scholarly InterestsMy current interest includes two principal areas:
1. The molecular basis for diseases in which the pathway of transcription-coupled DNA repair is defective, including Cockyne syndrome (CS) and UV-sensitive syndrome (UVSS). Patients are severely sensitive to sunlight but get no cancers. See Hanawalt & Spivak, 2008, for review.
2. Transcription arrest by guanine-rich DNA sequences and non-canonical secondary structures. Transcription collisions with replication forks. -
Steven Hancock, MD
Professor of Radiation Oncology (Radiation Therapy), Emeritus
Current Research and Scholarly InterestsOutcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
General adult and pediatric radiation therapy. -
Frank Hanley
Lawrence Crowley, M.D., Endowed Professor of Child Health
Current Research and Scholarly InterestsHis research and clinical work focuses on the development of interventional techniques for fetal and neonatal treatment of congenital heart disease, pulmonary, vascular physiology, and the neurologic impact of open-heart surgery. He developed and pioneered the unifocalization procedure, in which a single procedure is used to repair a complex and life-threatening congenital heart defect rather than several staged open-heart surgeries as performed by other surgeons.
-
Maha Hanna
Clinical Assistant Professor, Pediatrics
Current Research and Scholarly InterestsA bad latch means maternal excruciating pain, ineffective milk transfer with subsequent weight loss, hypoglycemia, higher risk of hyperbilirubinemia and dehydration fever.All of the above led to early cessation of breastfeeding; 46% of mothers who initiate exclusive breastfeeding stop within the first 12 weeks because of difficult latch. I developed a latch tutorial focusing on step-by step-in striations for achieving an effective, non-painful latch.
-
Josef Hannah
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Hannah graduated from Kansas City University of Medicine & Biosciences. He then completed a residency in Internal Medicine at the University of Kansas and a fellowship in Hospice & Palliative Medicine at Stanford University before joining as faculty at Stanford. His clinical practice includes both inpatient palliative care consultation as well as ambulatory care in palliative medicine. His research and educational interests include symptom management and utilizing media to grow palliative care services and education.
-
Mindy Hantke
Director of Communications, Psychiatry and Behavioral Sciences
Current Role at StanfordWeb & Communications Administration
-
Dina Hany
Postdoctoral Scholar, Biomedical Data Sciences
BioI am currently a postdoctoral researcher in the laboratory of Prof. Sylvia Plevritis, Department of Biomedical Data Sciences. My current work involves establishing drug testing platforms to evaluate tumor drug responses with respect to the tumor microenvironment and the its spatial organization. I hold a Ph.D. in Life Sciences (Pharmaceutical Sciences) from the University of Geneva, Switzerland, where I conducted research in Prof. Didier Picard's laboratory from 2017 to 2022. Prior to that, I earned a Master’s degree in Pharmacology and Experimental Therapeutics from Alexandria University, Egypt, and a Bachelor’s degree in Pharmacy with honors from Pharos University. My professional experience includes postdoctoral research in molecular pharmacology at UNIGE and a lecturer position in Pharmacotherapeutics and Cancer Biology at Pharos University. I have extensive teaching experience, supervising undergraduate and postgraduate courses, and have successfully guided master's thesis projects. My research has focused on endocrine resistance in breast cancer, utilizing CRISPR/Cas9 screens and exploring drug combinations, resulting in several relevant publications. I have presented my work at numerous conferences and received several awards, including the Ernst et Lucie Schmidheiny Fondation grant and the Ph.D. Booster prize from the faculty of medicine, Geneva, Switzerland. I am an active member of the Life Sciences Switzerland (LS2) and the European Association of Cancer Research (EACR).
-
Chenzhou Hao
Basic Life Res Scientist, Department of Neurobiology
BioMy expertise encompasses drug design, screening, and optimization. Currently, I am collaborating with my team to discover next-generation antiviral drugs targeting potentially pandemic viruses through structure-based drug discovery approaches.
My research interests include scientific visualization and structural biology, and I am eager to contribute to human health as a drug hunter in the future. In addition to my passion for research, I enjoy music, history, and architecture.
https://orcid.org/0000-0001-6803-7270 -
Md Enamul Haque
Biostatistician, Ophthalmology Research/Clinical Trials
Current Role at StanfordSr. Research Scientist
-
Pehr Harbury
Associate Professor of Biochemistry
Current Research and Scholarly InterestsScientific breakthroughs often come on the heels of technological advances; advances that expose hidden truths of nature, and provide tools for engineering the world around us. Examples include the telescope (heliocentrism), the Michelson interferometer (relativity) and recombinant DNA (molecular evolution). Our lab explores innovative experimental approaches to problems in molecular biochemistry, focusing on technologies with the potential for broad impact.
-
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations). -
Josef Hardi
Software Dvlpr 3, Computational Medicine
BioI'm a software engineer with over 15 years of experience building reliable, scalable software systems. I’m especially passionate about software engineering, data modeling, and the emerging potential of agentic large language models (LLMs).
I work at the Stanford Center for Biomedical Informatics Research, where I help develop Protégé and WebProtégé, which are tools used worldwide for creating and managing ontologies. Recently, I contributed to the Human BioMolecular Atlas Program (HuBMAP) project, where I helped build the Human Reference Atlas (HRA) knowledge graph and designed metadata schemas to support a range of assay datasets produced by the consortium.
My core technical strengths are in Java, JavaScript, and Python. I enjoy working at the intersection of software engineering and data to build tools that empower researchers and improve data interoperability. -
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.
Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health. -
Aubrey Hargrave
Temp - Non-Exempt, Ophthalmology Research/Clinical Trials
BioMy research interests are centered on ocular immunology and neuroinflammation. My long-standing interest in eye research stems from personal experience with eye disease, which has led me to explore vision research and underlies my passion for disease-centric research in order to improve quality of life for patients.
I am fascinated by the immune response and inflammation, in part because of its broad applicability to many human diseases. To this end, I am interested in developing an understanding of the interplay between the immune and nervous systems in the ocular microenvironment and my past research has allowed me to explore this interplay within diverse areas of the eye. As an undergraduate, I conducted research with Dr. Rima Mcleod to study patients with toxoplasmosis, a disease affecting both ocular and neural tissue. We created a patient database and investigated whether genotype influences the inflammatory response to the t.gondii parasite. As a predoctoral student with Dr. Alan Burns, my research focused on ocular inflammation in two cases; first, in acute inflammation following a corneal abrasion and second, in the context of systemic inflammation caused by early metabolic syndrome. I analyzed the immune response in both cases and developed methods to determine the effect on corneal nerves.
During my postdoctoral training with Dr. Alfredo Dubra, I am continuing to build on my previous training in vision science, inflammation, and neurodegeneration by using adaptive optics imaging, in conjunction with standard clinical measurements, to explore potential biomarkers in diseases such as multiple sclerosis, glaucoma, and retinal degeneration. With high-resolution in vivo adaptive optics imaging we are able to monitor changes in retinal tissues at the cellular level over time, as well as to observe minute changes in the retina with treatment during clinical trials. -
Brian A. Hargreaves
Professor of Radiology (Radiological Sciences Laboratory) and, by courtesy, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsI am interested in magnetic resonance imaging (MRI) applications and augmented reality applications in medicine. These include abdominal, breast and musculoskeletal imaging, which require development of faster, quantitative, and more efficient MRI methods that provide improved diagnostic contrast compared with current methods. My work includes novel excitation schemes, efficient imaging methods and reconstruction tools and augmented reality in medicine.
-
Prashant Hariharan
Postdoctoral Scholar, Neurosurgery
BioPrashant Hariharan is a biomedical engineer specializing in the design of "fit-for-purpose" in vitro models to study neurological disorders. He earned his B.E. from the University of Mumbai, an M.S. from the University of Texas at Arlington, an M.Eng. from Cornell University and a PhD from Wayne State University. His doctoral work with Dr. Carolyn A. Harris focused on developing an "organ-chip" model of the choroid plexus to study how cerebrospinal fluid secretion is affected by hydrocephalus. As a postdoctoral scholar in the Fame lab, Prashant is adding new layers of physiological complexity to his previous model to investigate how the body’s circadian clock regulates choroid plexus-driven cerebrospinal fluid production and composition. This work aspires to deliver model-driven insights that can be translated into CSF-centric therapies and ultimately advance the pursuit of precision medicine for brain health.
-
Stephanie Harman
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Stephanie Harman is a palliative care physician and Clinical Professor of Medicine. She graduated from Case Western Reserve University School of Medicine and went on to complete a residency in Internal Medicine at Stanford and a Palliative Care fellowship at the Palo Alto VA/Stanford program. She then joined the faculty at Stanford. She co-founded the Palliative Care Program at Stanford Health Care in 2007 and served as Clinical Chief of the Section of Palliative Care in the Division of Primary Care and Population Health from 2016 - 2022. She was the inaugural Associate Chair for Women in Medicine for the Department of Medicine and is now the Associate Chair for Faculty Engagement and Leadership Development. She is Director of the Stanford Leadership Development Program, a joint program between Stanford Health Care and the School of Medicine for emerging leaders. A 2017 Cambia Health Foundation Sojourns Scholar Leader Awardee, she has a passion for leadership development and faculty engagement; she has built multiple programs to support the careers of women leaders in academic medicine, both locally and nationally. Her other professional interests include clinical ethics and serious illness communication.
-
Keren Haroush
Assistant Professor of Neurobiology
Current Research and Scholarly InterestsOur laboratory studies the mechanisms by which highly complex behaviors are mediated at the neuronal level, mainly focusing on the example of dynamic social interactions and the neural circuits that drive them. From dyadic interactions to group dynamics and collective decision making, the lab seeks a mechanistic understanding for the fundamental building blocks of societies, such as cooperation, empathy, fairness and reciprocity.
-
Ciara Harraher, MD
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsI am interested in medical education and I am an Associate in the Practice of Medicine and doctoring with CARE ( E4C) Program. I am also interested in surgical outcomes research and I am involved in clinical trials studying brain tumors and stroke. I have also presented internationally on issues related to improving diversity in Neurosurgery.
